Drug intelligence / Profile preview

Fuzilizhong Decoction + Jinkui Shenqi Bolus

Development stage: Preclinical
Lead developer: Sanwa Shoyaku
Administration: Oral

Overview

A combination of two traditional Chinese medicine formulations. Fuzilizhong Decoction contains Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Rhizoma Zingiberis, and Radix Aconiti Lateralis Preparata. It has been studied for treating nonalcoholic fatty liver disease and shows anti-inflammatory properties. Jinkui Shenqi Bolus contains Radix Rehmanniae Preparata, Cortex Moutan, Rhizoma Dioscoreae, Fructus Corni, Rhizoma Alismatis, Poria, Ramulus Cinnamomi, Radix Aconiti Lateralis Preparata, Radix Achyranthis Bidentatae, and Semen Plantaginis. It is used to replenish kidney Yang deficiency in Traditional Chinese Medicine.

Other names: Fuzi-Lizhong Decoction + Jin Kui Shen Qi PianFuzi-Lizhong Decoction + Jin Kui Shen Qi WanFLD + Jin Kui Shen Qi Bolus

Beyond the preview

Go deeper on Fuzilizhong Decoction + Jinkui Shenqi Bolus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuzilizhong Decoction + Jinkui Shenqi Bolus.

Explore the full profile